卒中病例.pptVIP

* 23.01.08 PAR * 23.01.08 PAR * * 方法： 基于CAPRIE试验卒中亚组的卒中预测模型2 * 26.01.08 Antiplatelet therapy reduces vascular events, including non-fatal myocardial infarction, nonfatal stroke and vascular death in patients with previous stroke or TIA (RR 0.78; 95%CI 0.76-0.80) {Antithrombotic Trialists Collaboration, 2002 #9}. Aspirin Aspirin reduces recurrence independent of dose (50 to 1300 mg/d) {Algra, 1996 #7;The Dutch TIA Trial Study Group, 1991 #171;Farrell, 1991 #68;Campbell, 2007 #808}, although high doses (150mg/day) increase adverse events. In patients with symptomatic intracranial atherosclerosis